Jon OggWe are knee-deep in corporate earnings reports and markets are surging to new all-time highs. Investors and traders alike are wondering which stocks to buy and which to sell in the…
ThinkstockWith yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact of higher rates on stocks continues to be top of mind for…
ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on Monday by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) that it and Perrigo Co.…
August 5, 2013: U.S. equity markets opened lower this morning, lacking any major news of interest from around the globe. In Europe, eurozone non-manufacturing PMI rose slightly even though German PMI was…
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Monday, August 5, 2013. They include Chubb, Dow Chemical, Teva Pharmaceutical and Qualcomm.
Jon OggInvestors and traders are often on the hunt for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street…
ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that target rare or hard to treat diseases as orphan drug manufacturers. One…
Investors and traders are often on the hunt for fresh research ideas that will lead to higher income or more profits in this choppy stock and volatile market. 24/7 Wall St. reviews…
The research team at UBS A.G. (NYSE: UBS) has released what Wall Street calls a Q-GARP list, which is simply “quality growth at a reasonable price.” Most investors will know this by…
ThinkstockOver the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66% to 2.17%. The overall equity market has rallied 3.8% during this stretch…
Investors and traders frequently search for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls to find great ideas to find…
ThinkstockTotal return is always the name of the game when it comes to investing success. Stocks that pay dividends on a regular basis help smooth out the rough spots when the market…
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some…
As the stock market keeps hitting new highs, the spreads of high-yield bonds and junk bonds has been narrowing and narrowing. We even recently highlighted that these spreads were reaching what submariners…
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Abaxis Inc. (NASDAQ: ABAX) cut to Underperform from Neutral. Activision Blizzard Inc. (NASDAQ: ATVI)…
